APA (7th ed.) Citation

Azimirad, M., Hamtaeigashti, S., Raeisi, H., Looha, M. A., Gholami, F., Naser Moghadasi, A., . . . Yadegar, A. (2025). Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran. BMC neurology, 25(1), 234-12. https://doi.org/10.1186/s12883-025-04251-z

Chicago Style (17th ed.) Citation

Azimirad, Masoumeh, Sara Hamtaeigashti, Hamideh Raeisi, Mehdi Azizmohammad Looha, Fatemeh Gholami, Abdorreza Naser Moghadasi, Mohammad Reza Zali, and Abbas Yadegar. "Prevalence of Epsilon Toxin-producing Clostridium Perfringens Isolates Among Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Iran." BMC Neurology 25, no. 1 (2025): 234-12. https://doi.org/10.1186/s12883-025-04251-z.

MLA (9th ed.) Citation

Azimirad, Masoumeh, et al. "Prevalence of Epsilon Toxin-producing Clostridium Perfringens Isolates Among Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Iran." BMC Neurology, vol. 25, no. 1, 2025, pp. 234-12, https://doi.org/10.1186/s12883-025-04251-z.